915095-99-7
C31H35ClO11
619.06
1.33
98%+
N/A
N/A
N/A
A (Diabetes II)
Empagliflozin
SGLT2
N
| Availability: | |
|---|---|
Synthetic Roadmap
Are also in this series, click those CAS No. above
To check details
Illustrate
Acetyl empagliflozin is an intermediate in the synthesis of empagliflozin. Empagliflozin, co-developed by Boehringer Ingelheim and Eli Lilly, is a Chemicalbook sodium-glucose cotransporter (SGLT2) inhibitor for the treatment of type 2 diabetes. At present, it has been sold in the United States, Europe, Japan and other countries.
Safety Information
| UN No. : N/A | GIS Pic : N/A | P-Statement: N/A |
| H-Statement: N/A | Storage Temp: N/A | |
Download